Moderate-to-Severe Asthma May Be Underestimated

JANUARY 01, 2003
A recent telephone survey of more than 42,000 US households suggests that a majority of the population with asthma experiences moderate-to-severe persistent disease rather than mild illness. As reported in a recent issue of the American Journal of Respiratory and Critical Care Medicine, researchers analyzed data from 1788 people aged 16 and older who reported current asthma. Whereas previous studies suggested that most people with asthma have mild disease, 77.3% of the people in this study had moderate-to-severe persistent disease, and 10.7% had mild intermittent illness.

SHARE THIS SHARE THIS
0

Become A RESPIMAT T.O.P. Performer 

Get to know RESPIMAT, the slow-moving mist inhaler from Boehringer Ingelheim Pharmaceuticals, Inc.

Watch the RESPIMAT video and test your knowledge with a short multiple-choice quiz. When you get all the answers right, you’ll receive a certificate naming you a RESPIMAT T.O.P. Performer. Why not check it out today?


Pharmacy Times Strategic Alliance
 

Pharmacist Education
Clinical features with downloadable PDFs


Next-Generation Pharmacist® Awards


3rd Annual Convenient Healthcare and Pharmacy Collaborative Conference


SIGN UP FOR THE PHARMACY TIMES NEWSLETTER
Personalize the information you receive by selecting targeted content and special offers.